During the past decade, University Radiation Oncology at Parkridge Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 14 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Radiation Oncology at Parkridge Hospital" #1 sponsor was "University of Rochester" with 11 trials, followed by "Radiation Therapy Oncology Group" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Gynecologic Oncology Group" with 1 trials sponsored and "NSABP Foundation Inc" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Radiation Oncology at Parkridge Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "University Radiation Oncology at Parkridge Hospital" are "Prostate Cancer" (4 trials), "Breast Cancer" (3 trials), "Lung Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Fatigue" (2 trials). Many other conditions were trialed in "University Radiation Oncology at Parkridge Hospital" in a lesser frequency.

Most popular intervention types in "University Radiation Oncology at Parkridge Hospital" are "Radiation" (17 trials), "Drug" (13 trials), "Procedure" (6 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (3 trials), "Placebo" (3 trials), "Radiation Therapy" (3 trials), "3-Dimensional Conformal Radiation Therapy" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Radiation Oncology at Parkridge Hospital" are 19 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "University Radiation Oncology at Parkridge Hospital". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in University Radiation Oncology at Parkridge Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University Radiation Oncology at Parkridge Hospital, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".